HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David Sulzer Selected Research
David Sulzer Research Topics
Disease
56
Parkinson Disease (Parkinson's Disease)
04/2024 - 01/2002
10
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022 - 07/2003
6
Dyskinesias (Dyskinesia)
10/2021 - 01/2015
5
Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2019
5
Schizophrenia (Dementia Praecox)
01/2017 - 11/2005
4
Mitochondrial Diseases (Mitochondrial Disease)
11/2017 - 05/2007
4
Neuroinflammatory Diseases
08/2017 - 11/2003
3
Autism Spectrum Disorder
01/2024 - 01/2020
3
Synucleinopathies
01/2023 - 01/2022
3
Nervous System Diseases (Neurological Disorders)
01/2023 - 07/2008
3
Disease Progression
11/2021 - 01/2021
3
Huntington Disease (Huntington's Disease)
10/2021 - 05/2010
2
Autoimmune Diseases (Autoimmune Disease)
11/2023 - 01/2022
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2023 - 11/2006
2
Whooping Cough (Pertussis)
01/2023 - 11/2021
2
Inflammation (Inflammations)
03/2022 - 01/2020
2
Substance-Related Disorders (Drug Abuse)
03/2010 - 09/2002
2
Neuroblastoma
11/2006 - 07/2002
1
Pathologic Processes
04/2024
1
Shock
10/2023
1
Human Influenza (Influenza)
01/2023
1
Tetanus
01/2023
1
Motor Disorders
01/2022
1
Tuberous Sclerosis (Bourneville's Disease)
01/2022
1
Cognitive Dysfunction
01/2022
1
Multiple Sclerosis
01/2022
1
Autistic Disorder (Autism)
01/2022
1
Epilepsy (Aura)
01/2022
1
Basal Ganglia Diseases (Basal Ganglia Disease)
10/2021
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019
1
Disease Susceptibility (Diathesis)
01/2019
1
Fragile X Syndrome (Martin Bell Syndrome)
01/2019
1
Gaucher Disease (Gaucher's Disease)
01/2019
1
Neurodevelopmental Disorders
01/2018
Drug/Important Bio-Agent (IBA)
20
Dopamine (Intropin)
FDA Link
Generic
01/2024 - 09/2002
16
Proteins (Proteins, Gene)
FDA Link
02/2024 - 08/2004
16
Synucleins
IBA
11/2023 - 04/2013
12
neuromelanin
IBA
01/2022 - 01/2002
10
alpha-Synuclein
IBA
02/2024 - 10/2002
6
Levodopa (L Dopa)
FDA Link
Generic
10/2021 - 01/2015
4
Epitopes
IBA
11/2023 - 01/2017
4
Biomarkers (Surrogate Marker)
IBA
01/2023 - 11/2015
4
Neurotransmitter Agents (Neurotransmitter)
IBA
10/2016 - 07/2003
3
Antigens
IBA
01/2023 - 11/2021
3
Glucosylceramidase (Glucocerebrosidase)
IBA
12/2022 - 01/2019
3
Autoantigens
IBA
11/2021 - 01/2020
2
Norepinephrine (Noradrenaline)
FDA Link
Generic
10/2023 - 08/2017
2
Serine (L-Serine)
FDA Link
01/2023 - 01/2023
2
Iron
IBA
12/2022 - 08/2017
2
Enzymes
IBA
11/2022 - 01/2019
2
Neurotoxins
IBA
01/2022 - 03/2015
2
Sirolimus (Rapamycin)
FDA Link
01/2021 - 01/2019
2
Cholinergic Agents (Cholinergics)
IBA
01/2020 - 01/2016
2
Phosphotransferases (Kinase)
IBA
01/2019 - 04/2013
2
Lipids
IBA
01/2018 - 08/2014
2
Peptides (Polypeptides)
IBA
01/2017 - 01/2017
2
Glutamic Acid (Glutamate)
FDA Link
01/2017 - 03/2010
2
Antipsychotic Agents (Antipsychotics)
IBA
01/2016 - 01/2011
2
Huntingtin Protein
IBA
12/2011 - 05/2010
2
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
11/2006 - 03/2004
1
Therapeutic Uses
IBA
04/2024
1
Antidepressive Agents (Antidepressants)
IBA
04/2024
1
Hallucinogens (Psychedelics)
IBA
04/2024
1
Eukaryotic Initiation Factor-4E
IBA
01/2024
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
01/2024
1
Amino Acids
FDA Link
01/2023
1
Cholesterol
IBA
03/2022
1
Chemokines
IBA
03/2022
1
trans-sodium crocetinate (crocetin)
IBA
01/2022
1
Histocompatibility Antigens Class I
IBA
01/2022
1
TOR Serine-Threonine Kinases
IBA
01/2021
1
Proteome
IBA
01/2021
1
Valproic Acid (Depakote)
FDA Link
Generic
01/2020
1
Angiotensin-Converting Enzyme 2
IBA
01/2020
1
Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)
IBA
01/2020
1
Dynamin I
IBA
01/2019
1
mesoxalonitrile
IBA
01/2019
1
mitotracker green FM
IBA
01/2019
1
PTEN-induced putative kinase
IBA
01/2019
1
Beclin-1
IBA
01/2019
1
Red Fluorescent Protein
IBA
01/2019
1
Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)
IBA
01/2019
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2019
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
01/2019
1
tau Proteins (tau Protein)
IBA
01/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2019
1
Porins
IBA
01/2019
1
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
01/2019
1
Matrix Metalloproteinases (MMPs)
IBA
01/2019
1
quinone (benzoquinone)
IBA
01/2019
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2019
1
Cytochromes c (Cytochrome c)
IBA
01/2019
1
Green Fluorescent Proteins
IBA
01/2019
1
Voltage-Dependent Anion Channel 1
IBA
01/2019
1
Basic Helix-Loop-Helix Transcription Factors
IBA
01/2019
1
Fragile X Mental Retardation Protein
IBA
01/2019
1
Dopamine Receptors (Dopamine Receptor)
IBA
01/2018
1
Catecholamines
IBA
08/2017
Therapy/Procedure
11
Therapeutics
04/2024 - 07/2007
1
Self Administration (Administration, Self)
10/2021